Furthermore, p100 processing to p52 was evident in most Ndrg2-deficient lymphoma cells, suggesting that the loss of NDRG2 involves the activation of the canonical and non-canonical NF-κB signaling pathway in vivo. Here, NFKB1 is linked to lymphoma.